63.9% of Population Fully Vaccinated... 1.36 Million Doses of Pfizer Arrive

Possibility of Early Achievement of '70%' Vaccination Completion Rate
(Seoul=Yonhap News) Reporter Seomyeong Gon = On the afternoon of the 13th, citizens are waiting for monitoring of adverse reactions after receiving the COVID-19 vaccine at the Songpa-gu Vaccination Center installed in the Songpa-gu Sports and Culture Center in Seoul.
As the government announced the transition of the quarantine system to 'gradual daily recovery' early next month, the speed of COVID-19 vaccination in the country is accelerating, raising expectations that the existing schedule may be advanced. According to government officials on the day, the target date for achieving the '70% nationwide vaccination completion rate,' which is the criterion for the transition of the quarantine system, is likely to be earlier than the government's expected date of the 23rd of this month. 2021.10.13
seephoto@yna.co.kr
(End)


＜Copyright(c) Yonhap News Agency, unauthorized reproduction and redistribution prohibited＞

[Asia Economy Reporter Junhyung Lee] As the number of people who have completed COVID-19 vaccination rapidly increases, 1,369,000 doses of Pfizer vaccine, individually contracted with Pfizer, arrived at Incheon Airport on the 16th.

According to the COVID-19 Vaccination Response Promotion Team on that day, as of the 15th, the number of people who have completed vaccination was 718,818. By vaccine type, 516,935 received Pfizer, 173,141 Moderna, and 26,688 AstraZeneca (AZ). Although 35,912 people were counted as having completed AstraZeneca vaccination, 9,224 of them received a cross-vaccination with Pfizer vaccine for the second dose. Currently, four types of vaccines?Pfizer, Janssen, Moderna, and AstraZeneca?are being administered domestically.

The cumulative number of completed vaccinations was counted at 32,812,800 doses, corresponding to 63.9% of the total population. The vaccination completion rate for the population aged 18 and over is 74.3%. By vaccine, Pfizer accounts for 17,540,465 doses, AstraZeneca 10,802,907 doses, and Moderna 2,998,970 doses. The remainder are Janssen recipients.

The vaccination completion rate by gender is slightly higher for females (65.6%) than males (62.2%). By age group, those in their 60s had the highest completion rate at 91.9%, followed by those in their 70s at 91.5%, 50s at 91.3%, and those aged 80 and above at 81.1%. Among the younger and middle-aged groups, where vaccination started relatively late, the rates were 60.0% for those in their 40s, 57.9% for ages 18?29, and 57.7% for those in their 30s. The completion rate for those aged 17 and under was 0.6%.

Mutual Vaccine Donation from the UK: 94,000 Doses Arrived
(Seoul=Yonhap News) On the afternoon of the 7th, among the 1 million doses of Pfizer vaccine secured through the mutual vaccine donation agreement with the UK, 94,000 doses arrived at Incheon International Airport and are being transferred. October 7, 2021. [Provided by the Disease Control Agency Transport Support Headquarters. Resale and DB prohibited]
Photo by Yonhap News
(End)


＜Copyright(c) Yonhap News Agency, Unauthorized reproduction and redistribution prohibited＞

New cases of adverse reactions reported to health authorities by vaccine recipients reached 8,637 over the two days from the 14th to the 15th. During the same period, 18 additional death reports were made. Authorities plan to investigate the causal relationship between vaccination and deaths. Reports suspected of anaphylaxis, a severe systemic allergic reaction, increased by 22 cases. Major adverse reaction cases, including intensive care unit admissions, increased by 229. Since the start of vaccination in Korea on February 26 this year, the cumulative number of suspected adverse reaction reports is 320,910, and death reports total 781.

Meanwhile, the government announced that 1,369,000 doses of individually contracted Pfizer vaccine arrived at Incheon Airport on this day. The total vaccine doses supplied domestically amount to 82,310,000. The government stated that it will closely coordinate with pharmaceutical companies to ensure stable vaccine supply and promptly provide detailed supply schedules.